
Proteomics Market Size, Share, and Analysis, By Product (Instrumentation Technologies, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, and Others), By End User (Pharmaceutical & Biotech
Description
Proteomics Market Size, Share, and Analysis, By Product (Instrumentation Technologies, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, and Others), By End User (Pharmaceutical & Biotechnology Companies, Research & Clinical Laboratories, Hospitals, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Proteomics Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 14.1% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 33.2 billion and is projected to reach USD 142.7 billion by the completion of 2034.
Proteomics is the broad study of proteins, including their functions and structures. Its goal is to comprehend an organism, along with tissue or the full protein complement of the cell under certain conditions. Proteomics uses mass spectrometry and chromatography techniques to identify and measure proteins and study their functions in numerous biological processes. Unlike genomics, which focuses on DNA, proteomics emphasizes on the dynamic aspects of biological operations as proteins are the major carriers of genetic instructions. Besides, this field is important for understanding the cause of disease and designing personalized therapeutics in medicine and biotechnology.
MARKET HIGHLIGHTS
Proteomics Market is projected to reach USD 142.7 billion over the forecast period, due to technological innovations and its growing usage in drug discovery and personalized medicine. The growth is attributed to developments in high-resolution mass spectrometry and protein analysis tools, which improve the accuracy of protein characterization. In addition, the focus on understanding complex biological processes and the need for new treatment targets are also boosting market demand. Businesses are investing in creative solutions and combining proteomics with other omics technologies to provide a better understanding of biological systems. Thus, the proteomics market provides a variety of products and services such as reagents and software to meet different research and clinical requirements.
Proteomics Market Segments:
Growth Drivers
Technological Expansions is Driving Growth in the Proteomics Market
Rising Demand for Personalized Medicine Act as a Catalyst for Market Growth
Restraint
High Initial Costs in the Market Will Impact the Growth
Key Players
PRODUCT OVERVIEW
Proteomics Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 14.1% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 33.2 billion and is projected to reach USD 142.7 billion by the completion of 2034.
Proteomics is the broad study of proteins, including their functions and structures. Its goal is to comprehend an organism, along with tissue or the full protein complement of the cell under certain conditions. Proteomics uses mass spectrometry and chromatography techniques to identify and measure proteins and study their functions in numerous biological processes. Unlike genomics, which focuses on DNA, proteomics emphasizes on the dynamic aspects of biological operations as proteins are the major carriers of genetic instructions. Besides, this field is important for understanding the cause of disease and designing personalized therapeutics in medicine and biotechnology.
MARKET HIGHLIGHTS
Proteomics Market is projected to reach USD 142.7 billion over the forecast period, due to technological innovations and its growing usage in drug discovery and personalized medicine. The growth is attributed to developments in high-resolution mass spectrometry and protein analysis tools, which improve the accuracy of protein characterization. In addition, the focus on understanding complex biological processes and the need for new treatment targets are also boosting market demand. Businesses are investing in creative solutions and combining proteomics with other omics technologies to provide a better understanding of biological systems. Thus, the proteomics market provides a variety of products and services such as reagents and software to meet different research and clinical requirements.
Proteomics Market Segments:
- By Product
- Instrumentation Technologies
- Reagents & Consumables
- Software & Services
- By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Others
- By End User
- Pharmaceutical & Biotechnology Companies
- Research & Clinical Laboratories
- Hospitals
- Others
Growth Drivers
Technological Expansions is Driving Growth in the Proteomics Market
Rising Demand for Personalized Medicine Act as a Catalyst for Market Growth
Restraint
High Initial Costs in the Market Will Impact the Growth
Key Players
- Thermo Fisher Scientific
- Agilent Technologies
- Bio-Rad Laboratories
- Bruker Corporation
- AB Sciex
- GE Healthcare
- PerkinElmer
- Waters Corporation
- SABiosciences (Qiagen)
- Cell Signaling Technology
- Invitrogen
- Proteome Sciences
- Molecular Devices
- Illumina
- NanoString Technologies
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Table of Contents
597 Pages
- 1. Executive Summary
- 1.1. Regional Market Share
- 1.2. Business Trends
- 1.3. Proteomics Market: COVID-19 Outbreak
- 1.4. Regional Trends
- 1.5. Segmentation Snapshot
- 2. Research Methodology
- 2.1. Research Objective
- 2.2. Research Approach
- 2.3. Data Sourcing and Methodology
- 2.4. Primary Research
- 2.5. Secondary Research
- 2.5.1. Paid Sources
- 2.5.2. Public Sources
- 2.6. Market Size Estimation and Data Triangulation
- 3. Market Characteristics
- 3.1. Market Definition
- 3.2. Proteomics Market: COVID-19 Impact
- 3.3. Key Segmentations
- 3.4. Key Developments
- 3.5. Allied Industry Data
- 4. Proteomics Market – Industry Insights
- 4.1. Industry Segmentation
- 4.2. COVID-19 overview of world economy
- 4.3. Industry Ecosystem Channel Analysis
- 4.4. Innovation & Sustainability
- 5. Macroeconomic Indicators
- 6. Recent Developments
- 7. Market Dynamics
- 7.1. Introduction
- 7.2. Growth Drivers
- 7.3. Market Opportunities
- 7.4. Market Restraints
- 7.5. Market Trends
- 8. Risk Analysis
- 9. Market Analysis
- 9.1. Porter's Five Forces
- 9.2. PEST Analysis
- 9.2.1. Political
- 9.2.2. Economic
- 9.2.3. Social
- 9.2.4. Technological
- 10. Proteomics Market
- 10.1. Overview
- 10.2. Historical Analysis (2019-2022)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11. Proteomics Market Size & Forecast 2024 A-2034 F
- 11.1. Overview
- 11.2. Key Findings
- 11.3. Market Segmentation
- 11.3.1. By Product
- 11.3.1.1. Instrumentation Technologies
- 11.3.1.1.1. By Value (USD Million) 2024-2034 F
- 11.3.1.1.2. Market Share (%) 2024-2034 F
- 11.3.1.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.2. Reagents & Consumables
- 11.3.1.2.1. By Value (USD Million) 2024-2034 F
- 11.3.1.2.2. Market Share (%) 2024-2034 F
- 11.3.1.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.1.3. Software & Services
- 11.3.1.3.1. By Value (USD Million) 2024-2034 F
- 11.3.1.3.2. Market Share (%) 2024-2034 F
- 11.3.1.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2. By Application
- 11.3.2.1. Clinical Diagnostics
- 11.3.2.1.1. By Value (USD Million) 2024-2034 F
- 11.3.2.1.2. Market Share (%) 2024-2034 F
- 11.3.2.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.2. Drug Discovery and Development
- 11.3.2.2.1. By Value (USD Million) 2024-2034 F
- 11.3.2.2.2. Market Share (%) 2024-2034 F
- 11.3.2.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.2.3. Others
- 11.3.2.3.1. By Value (USD Million) 2024-2034 F
- 11.3.2.3.2. Market Share (%) 2024-2034 F
- 11.3.2.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3. By End User
- 11.3.3.1. Pharmaceutical & Biotechnology Companies
- 11.3.3.1.1. By Value (USD Million) 2024-2034 F
- 11.3.3.1.2. Market Share (%) 2024-2034 F
- 11.3.3.1.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.2. Research & Clinical Labs
- 11.3.3.2.1. By Value (USD Million) 2024-2034 F
- 11.3.3.2.2. Market Share (%) 2024-2034 F
- 11.3.3.2.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.3. Hospitals
- 11.3.3.3.1. By Value (USD Million) 2024-2034 F
- 11.3.3.3.2. Market Share (%) 2024-2034 F
- 11.3.3.3.3. Y-o-Y Growth (%) 2024-2034 F
- 11.3.3.4. Others
- 11.3.3.4.1. By Value (USD Million) 2024-2034 F
- 11.3.3.4.2. Market Share (%) 2024-2034 F
- 11.3.3.4.3. Y-o-Y Growth (%) 2024-2034 F
- 12. North America Proteomics Market Size & Forecast 2024 A-2034 F
- 12.1. Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1. By Product
- 12.3.2. By Application
- 12.3.3. By End User
- 12.4. Country
- 12.4.1. United States
- 12.4.2. Canada
- 13. Europe Proteomics Market Size & Forecast 2024 A-2034 F
- 13.1. Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1. By Product
- 13.3.2. By Application
- 13.3.3. By End User
- 13.4. Country
- 13.4.1. Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14. Asia-Pacific Proteomics Market Size & Forecast 2024 A-2034 F
- 14.1. Overview
- 14.2. Key Findings
- 14.3. Market Segmentation
- 14.3.1. By Product
- 14.3.2. By Application
- 14.3.3. By End User
- 14.4. Country
- 14.4.1. India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4. Japan
- 14.4.5. Rest of APAC
- 15. Middle East and Africa Proteomics Market Size & Forecast 2024 A-2034 F
- 15.1. Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1. By Product
- 15.3.2. By Application
- 15.3.3. By End User
- 15.4. Country
- 15.4.1. Israel
- 15.4.2. GCC
- 15.4.3. North Africa
- 15.4.4. South Africa
- 15.4.5. Rest of Middle East and Africa
- 16. Latin America Proteomics Market Size & Forecast 2024 A-2034 F
- 16.1. Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1. By Product
- 16.3.2. By Application
- 16.3.3. By End User
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2. Brazil
- 16.4.3. Rest of Latin America
- 17. Competitive Landscape
- 17.1. Company market share, 2023
- 17.2. Key player overview
- 17.3. Key stakeholders
- 18. Company Profiles
- 18.1. Thermo Fisher Scientific
- 18.1.1. Company Overview
- 18.1.2. Financial Overview
- 18.1.3. Key Product; Analysis
- 18.1.4. Company Assessment
- 18.1.4.1. Product Portfolio
- 18.1.4.2. Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2. Agilent Technologies
- 18.3. Bio-Rad Laboratories
- 18.4. Bruker Corporation
- 18.5. GE Healthcare
- 18.6. AB Sciex
- 18.7. PerkinElmer
- 18.8. Waters Corporation
- 18.9. SABiosciences (Qiagen)
- 18.10. Cell Signaling Technology
- 18.11. Invitrogen
- 18.12. Proteome Sciences
- 18.13. Molecular Devices
- 18.14. Illumina
- 18.15. NanoString Technologies
- 18.16. Other Prominent Players
- 19. Appendix
- 20. Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.